Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when MKC files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsMcCormick appoints former AstraZeneca digital chief Cindy Hoots to Board
Filed May 26, 2026 · Period ending May 19, 2026 · ~1 min read
Key Changes
-
medium
Cindy Hoots, former Chief Digital Officer and CIO at AstraZeneca, joins McCormick's Board effective June 1, 2026, and will serve on the Audit Committee.
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR → -
low
Board expands to 12 directors, 11 of whom are independent, reflecting ongoing board refreshment aligned with strategic priorities.
Exhibit 99.1 view on EDGAR →
Summary
McCormick appointed Cindy Hoots to its Board of Directors effective June 1, 2026. Ms. Hoots brings technology and digital transformation expertise from her tenure as Chief Digital Officer and CIO at AstraZeneca, along with consumer packaged goods experience from her prior role as Global Vice President, Technology at Unilever. She currently serves on the board of Zoom Communications.
The appointment expands McCormick's Board to 12 directors, maintaining strong independence with 11 independent members. Ms. Hoots will join the Audit Committee and receive standard non-executive director compensation. This is a routine board refreshment that adds relevant digital and technology expertise to McCormick's governance structure as the company continues to modernize its operations.
Section-by-Section Diff
Event · Exhibit 99.1
Added in current filing · view on EDGAR →
McCormick & Company, Incorporated (NYSE:MKC), a global leader in flavor, today announced that Cindy Hoots, former Chief Digital Officer & CIO, AstraZeneca PLC, has been appointed to the Board of Directors of McCormick effective June 1, 2026.
McCormick appointed Cindy Hoots to its Board of Directors effective June 1, 2026. Ms. Hoots brings technology and digital transformation expertise from her prior roles as Chief Digital Officer & CIO at AstraZeneca and Global Vice President, Technology at Unilever, along with experience in the consumer packaged goods sector.
Show 1 minor / wording change
Added in current filing · view on EDGAR →
With this appointment, the Board of Directors of McCormick will be comprised of 12 directors, 11 of which are independent.
Following this appointment, McCormick's Board will consist of 12 directors, with 11 being independent. This reflects the company's ongoing board refreshment process to maintain a balanced mix of skills and perspectives aligned with strategic priorities.
Event · Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
On May 19, 2026, the Board of the McCormick & Company, Incorporated (the “Company”) appointed Cindy Hoots to the Board of the Company with effect from June 1, 2026, on which date she will become a member of the Audit Committee of the Board. Ms. Hoots is the recently retired Chief Digital Officer and CIO of AstraZeneca PLC, and is a member of the Board of Directors, of Zoom Communications, Inc.
McCormick appointed Cindy Hoots to its Board of Directors effective June 1, 2026, where she will join the Audit Committee. Ms. Hoots brings technology and digital expertise from her prior role as Chief Digital Officer and CIO at AstraZeneca and her current board service at Zoom Communications. She will receive standard non-executive director compensation as described in the company's February 2026 proxy statement.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 30, 2026 · How we verify